The Global Adult
and Pediatric Hemoconcentrators Market, by Product Type (Adult
Hemoconcentrators and Pediatric Hemoconcentrators), by End User (Hospital,
Ambulatory Surgical Centers, and Others), and by Region (North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 10.7
Mn in 2017, and is projected to exhibit a CAGR of 3.3% during the forecast
period (2018–2026).
High prevalence of cardiovascular
diseases is expected to increase demand for hemoconcentrators, which in turn is
expected to drive the global adult and pediatric hemoconcentrators market
growth over the forecast period. According to study published by the World
Health Organization (WHO), in 2015, globally, around 7.4 million people died
due to coronary heart diseases; and according to the Centers for Disease
Control and Prevention (CDC), in 2016, around 8.5 million people in the U.S.
suffered from peripheral artery diseases. According to the data published by
the National Center for Biotechnology Information in 2016, in the U.S., over 350,000
people suffered from out-of-hospital cardiac arrest (OHCA) and about 209,000
from in-hospital cardiac arrest (IHCA), with a survival rate of 12% and 24.9%,
respectively Such high prevalence of cardiovascular diseases is expected to
increase demand for hemoconcentrators during surgical procedures and thus,
support adult and pediatric hemoconcentrators market growth over the forecast
period.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2483
Browse 18 Market Data Tables and
23 Figures spread through 120 Pages and in-depth TOC on Global Adult and
Pediatric Hemoconcentrators Market, by Product Type (Adult Hemoconcentrators,
and Pediatric Hemoconcentrators), by End User (Hospital, Ambulatory Surgical
Centers, and Others), and Region (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa) - Global Forecast to 2026
Furthermore, advantages offered
by hemoconcentrator devices is expected to rise its adoption and support global
adult and pediatric hemoconcentrators market growth during the forecast period.
For instance, according to the data published by Annals of Thoracic Surgery in
2013, hemoconcentrator functions without technical failures and offers
complementary technique in blood management during cardiac operations. Key players
in the market are involved in strategic partnerships and collaboration
activities for expanding their presence in the market and to gain major market
share. Such strategic activities are expected to increase adoption of
hemoconcentrators in different economies and support market growth in the near
future. For instance, in 2016, MEDIVATORS Inc. (a Cantel Medical Corporation
company), a manufacturer of Hemocor HPH family hemoconcentrators, expanded its
direct sales operations in Canada by acquiring endoscope reprocessing business
assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of
Diploma Canada Holdings Ltd.
Key Takeaways of the Adult and
Pediatric Hemoconcentrators Market:
The global adult and pediatric
hemoconcentrators market is expected to exhibit a CAGR of 3.3% during the
forecast period (2018 – 2026), owing to frequent product launches and
approvals, and robust pipeline of novel adult and pediatric hemoconcentrators
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/adult-and-pediatric-hemoconcentrators-market-2483
North America is expected to hold
dominant position in global adult and pediatric hemoconcentrators market over
the forecast period, owing to high prevalence of cardiovascular diseases and
increasing healthcare awareness in the region
China and India are expected to
exhibit high growth in Asia Pacific adult and pediatric hemoconcentrators
market, due to rising geriatric population who are more prone to cardiovascular
diseases
Key players such as Medtronic
Plc. and distribute hemoconcentrators manufactured by Medivators Inc. in
various key regions
Key players are adopting
strategic mergers and acquisitions strategy in order to expand its product
portfolio and market presence. For instance, in 2015, Sorin S.p.A, a provider
of hemoconcentrators, merged with a U.S.-based company, Cyberonics, Inc. The
newly formed company was named LivaNova, Plc.
Major players operating in the
global adult and pediatric hemoconcentrators market include Medivators Inc.,
Terumo Corporation, LivaNova, PLC, Maquet (a Getinge Group company), Medica
S.p.A,, and others
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2483
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment